Search Results - "Behalova K"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion.

    Authors: Kilic IB Weberova P VanDyke D et al.

    Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Aug 11; Vol. 13 (8). Date of Electronic Publication: 2025 Aug 11.

    Publication Type: Journal Article

    Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

    Save to List
  2. 2

    Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.

    Authors: Matuskova H Marasek P Mazhara V et al.

    Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Apr 17; Vol. 13 (4). Date of Electronic Publication: 2025 Apr 17.

    Publication Type: Journal Article

    Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

    Save to List
  3. 3

    Advances in IL-15-Based Cancer Immunotherapy and Divergent Immunological Effects of IL-2 and IL-15 Signaling via the Shared IL-2Rβγ Receptor.

    Authors: Gao H Ma T Jiang Q et al.

    Source: Frontiers in immunology [Front Immunol] 2026 Apr 10; Vol. 17, pp. 1791059. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicity.

    Authors: Pousse L Manchala A Klein C et al.

    Source: MAbs [MAbs] 2025 Dec; Vol. 17 (1), pp. 2590250. Date of Electronic Publication: 2025 Nov 14.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List

Search Tools: